Azenta, Inc.
PublicLast Round
Buyout/LBO
Feb 1, 2022
Est. Valuation
$3B
Total Funding Raised
$3B
Company Overview
Azenta, Inc. is a biotechnology company that provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies.
AI Layer
Non-AI
Keywords
sample managementautomated sample storagelab automationbiorepository servicesgenomic servicescryogenic storageLIMSgene sequencinglife science toolscold chain logisticsmultiomics servicesNGSnext-generation sequencingbiobankinggene synthesislaboratory information management systemlab consumablesSanger sequencing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azenta, Inc. Comps
Public and private peers based on sector, stage, and business model.
Azenta, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Feb 1, 2022 |
Azenta, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thomas H. Lee Partners | Buyout/LBO |
Azenta, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
Headquarters—
Employee Range1,246
Year Founded1978
Last FundingFeb 1, 2022
